Alzheimer’s disease (AD) is a degenerative cognition-declining disease with no clear understanding of the underlying mechanisms. Currently, no effective therapeutics are available for AD. Amyloid-β (A-β) plaques and tau tangles were considered as the contributing factors to the development of AD. In contrast, controversial exists due to efforts focusing on A-β as a pharmacological therapeutic target was failed. Emerging evidence appeared for the external stimuli applied through vision (LED) and hearing (~40Hz) to certain intensity to dementia subjects with promising results such as reducing A-β and tau tangles in the brain tissue, increasing the brain volume reducing the decline of daily activities and mental status. This optogenetic and so...
Worldwide, statistics suggest that by the year 2050 as many as 80 million individuals will be living...
This study assessed the effect of stimulating the somatosensory system of Alzheimer’s disease (AD) p...
In the context of population aging, the growing problem of Alzheimer’s disease (AD) poses a great ch...
This abstract will be presented as a poster at the 4th International Brain Stimulation Conference, i...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder. AD pathology is characterized ...
Alzheimer's disease (AD) is the most prevalent chronic neurodegenerative disease. Current approved t...
IntroductionWith no cure or effective treatment, the prevalence of patients with Alzheimer’s disease...
This paper provides an overview of the information and research conducted that ushered the creatio...
Alzheimer’s disease (AD) is recognized as a major health hazard that mostly affects people older tha...
Alzheimer's disease (AD) is a growing global health crisis, however, there are currently very few ef...
Alzheimer’s disease (AD) is an irreversible, progressive brain disorder that slowly destroys the mem...
Premis Pharmanews-Fedefarma 2019A few months ago, a promising study about Alzheimer Disease (AD), a ...
Despite decades of research, Alzheimer’s Disease (AD) remains a lethal neurodegenerative disorder fo...
Introduction: Alzheimer’s disease (AD) is characterized by the decline of cognitive functions such a...
Pathological proteins contributing to Alzheimer’s disease (AD) are known to disrupt normal neuronal ...
Worldwide, statistics suggest that by the year 2050 as many as 80 million individuals will be living...
This study assessed the effect of stimulating the somatosensory system of Alzheimer’s disease (AD) p...
In the context of population aging, the growing problem of Alzheimer’s disease (AD) poses a great ch...
This abstract will be presented as a poster at the 4th International Brain Stimulation Conference, i...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder. AD pathology is characterized ...
Alzheimer's disease (AD) is the most prevalent chronic neurodegenerative disease. Current approved t...
IntroductionWith no cure or effective treatment, the prevalence of patients with Alzheimer’s disease...
This paper provides an overview of the information and research conducted that ushered the creatio...
Alzheimer’s disease (AD) is recognized as a major health hazard that mostly affects people older tha...
Alzheimer's disease (AD) is a growing global health crisis, however, there are currently very few ef...
Alzheimer’s disease (AD) is an irreversible, progressive brain disorder that slowly destroys the mem...
Premis Pharmanews-Fedefarma 2019A few months ago, a promising study about Alzheimer Disease (AD), a ...
Despite decades of research, Alzheimer’s Disease (AD) remains a lethal neurodegenerative disorder fo...
Introduction: Alzheimer’s disease (AD) is characterized by the decline of cognitive functions such a...
Pathological proteins contributing to Alzheimer’s disease (AD) are known to disrupt normal neuronal ...
Worldwide, statistics suggest that by the year 2050 as many as 80 million individuals will be living...
This study assessed the effect of stimulating the somatosensory system of Alzheimer’s disease (AD) p...
In the context of population aging, the growing problem of Alzheimer’s disease (AD) poses a great ch...